Last month, an ambitious plan was presented in France. The goal is to place genome sequencing at the heart of clinical practice in next 10 years. It is very interesting to see that this plan puts the patient at the center to go to personalized medecine and aims at encouraging links between public research and business companies. It is a real opportunity to put France in the learder group of countries involved in genomic medicine. As we integrate CHOPIN Project (CHolesterol Personalized INnovation), We are proud to be a part of this French Plan for Genomic Medicine 2025.

The establishment of a national genomic medicine sector, which can be a lever for scientific and technological innovation, technology transfer and economic growth, will require involvement from the relevant industries along with academic research and public health bodies.

Source: Presentation of the French Plan for Genomic Medicine 2025 | Newsroom | Inserm

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.